Segall Bryant & Hamill LLC grew its stake in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 11.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 820,518 shares of the specialty chemicals company’s stock after buying an additional 81,550 shares during the period. Innophos accounts for approximately 0.9% of Segall Bryant & Hamill LLC’s holdings, making the stock its 28th biggest holding. Segall Bryant & Hamill LLC owned approximately 4.20% of Innophos worth $40,361,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Personal Capital Advisors Corp boosted its position in Innophos by 2.7% during the 3rd quarter. Personal Capital Advisors Corp now owns 60,902 shares of the specialty chemicals company’s stock worth $2,996,000 after purchasing an additional 1,603 shares during the period. American Century Companies Inc. boosted its position in Innophos by 68.8% during the 2nd quarter. American Century Companies Inc. now owns 612,435 shares of the specialty chemicals company’s stock worth $26,849,000 after purchasing an additional 249,585 shares during the period. Prudential Financial Inc. boosted its position in Innophos by 38.5% during the 2nd quarter. Prudential Financial Inc. now owns 172,021 shares of the specialty chemicals company’s stock worth $7,541,000 after purchasing an additional 47,830 shares during the period. Marshall Wace North America L.P. purchased a new stake in Innophos during the 2nd quarter worth $2,556,000. Finally, Dimensional Fund Advisors LP boosted its position in Innophos by 0.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 973,461 shares of the specialty chemicals company’s stock worth $42,676,000 after purchasing an additional 3,717 shares during the period. 94.46% of the stock is owned by hedge funds and other institutional investors.

Innophos Holdings, Inc. (IPHS) opened at $45.49 on Thursday. Innophos Holdings, Inc. has a 1-year low of $41.66 and a 1-year high of $58.22. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.86 and a quick ratio of 1.49. The company has a market cap of $902.63, a price-to-earnings ratio of 18.79 and a beta of 0.86.

Innophos (NASDAQ:IPHS) last issued its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.78 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. Innophos had a net margin of 6.19% and a return on equity of 13.90%. The firm had revenue of $184.00 million for the quarter, compared to analyst estimates of $179.33 million. During the same quarter in the previous year, the business posted $0.69 EPS. The firm’s revenue was down 1.1% compared to the same quarter last year. equities analysts expect that Innophos Holdings, Inc. will post 2.5 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th were issued a $0.48 dividend. The ex-dividend date of this dividend was Thursday, November 16th. This represents a $1.92 dividend on an annualized basis and a yield of 4.22%. Innophos’s dividend payout ratio is currently 88.48%.

A number of brokerages recently weighed in on IPHS. BidaskClub cut shares of Innophos from a “hold” rating to a “sell” rating in a research report on Tuesday. KeyCorp reaffirmed a “hold” rating on shares of Innophos in a research report on Wednesday, November 1st. Finally, Zacks Investment Research cut shares of Innophos from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 4th.

WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/segall-bryant-hamill-llc-increases-stake-in-innophos-holdings-inc-iphs/1748872.html.

Innophos Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.